![\"2026](\"https:\/\/www.medgencetec.com\/uploads\/2026-J.P.-Morgan-Healthcare-Conference.jpg\")
<\/a><\/p>\nAI + CXO Platform Driving TCM Innovation<\/p>\n
As a leading Chinese TCM CXO (Contract Research, Development, and Manufacturing Organization) enterprise, YINENG Pharma represents a vivid example of “China’s iteration speed.”<\/p>\n
In his presentation, Dr. Yi focused on the theme of the “AI + CXO TCM Innovation Technology Platform,” explaining how the company has built a full-industry-chain competitive advantage in TCM R&D:<\/p>\n
- \n
- A 50,000 m² integrated R&D laboratory and intelligent pilot-scale research base, enabling seamless processes from raw herbal research to formulation manufacturing<\/li>\n
- A multidisciplinary research team of nearly 400 experts led by academicians<\/li>\n
- A comprehensive TCM database covering 592 single herbs and over 1.6 million batches of research data<\/li>\n<\/ul>\n
Together, these capabilities form a closed-loop system of data-driven R&D and AI-enabled industrialization<\/strong>.<\/p>\n
Case Study: Linggui Zhugan Granules Development<\/p>\n
Dr. Yi highlighted the development of the approved classical formula Linggui Zhugan Decoction granules<\/strong> as a key example:<\/p>\n
- \n
- AI algorithms were used to accurately define standards for geo-authentic medicinal materials<\/li>\n
- Machine learning optimized extraction processes, significantly shortening the development cycle<\/li>\n
- Clinical efficacy data supported predictive modeling, improving formulation evaluation accuracy<\/li>\n<\/ul>\n
To date, YINENG Pharma has:<\/p>\n
- \n
- Completed standardized research on 97 classical TCM formulas<\/li>\n
- Advanced 26 innovative TCM drug development projects<\/li>\n
- Provided technical support to over 100 pharmaceutical companies and 200 hospitals<\/li>\n
- Helped clients obtain 67 drug approvals<\/li>\n<\/ul>\n
These tangible achievements impressed many international participants, who noted that TCM innovation can also achieve remarkable “technological acceleration.”<\/p>\n
Global Attention on AI + CXO Model<\/p>\n
During networking sessions at the conference, the pace of global innovation was seen to be increasingly influenced by East Asia—especially China’s R&D efficiency.<\/p>\n
YINENG Pharma’s “AI + CXO” model became a focal point for multinational pharmaceutical companies and investment institutions. In response to growing global interest, Dr. Yi outlined a clear internationalization strategy:<\/p>\n
- \n
- Establish regional service centers in Europe and North America within the next three years<\/li>\n
- Expand the AI + CXO model to global partners<\/li>\n
- Promote integration between TCM and the global healthcare system<\/li>\n<\/ul>\n
This appearance marked the first global capital market showcase of AI-powered TCM innovation technologies<\/strong>.<\/p>\n
![\"2026](\"https:\/\/www.medgencetec.com\/uploads\/2026-J.P.-Morgan-Healthcare-Conference-1.jpg\")
<\/a><\/p>\nStrong R&D Infrastructure Supporting Global Expansion<\/p>\n
YINENG Pharma’s global ambitions are backed by robust domestic R&D capabilities. The company has established an integrated innovation and industrial platform consisting of:<\/p>\n
- \n
- Five major research institutes<\/li>\n
- Six clinical application centers<\/li>\n
- Seven core technology platforms<\/li>\n<\/ul>\n
Equipped according to GMP standards, the facilities include pilot-scale extraction systems, spray dryers, and one-step granulation equipment, ensuring seamless integration between R&D and manufacturing.<\/p>\n
This advanced digital TCM research center—one of the largest in China—serves as both the core engine of the AI + CXO platform and a technological landmark for TCM innovation.<\/p>\n
From Chinese Characteristics to Global Consensus<\/p>\n
“The modernization of traditional Chinese medicine requires both deep local roots and a global perspective,” Dr. Yi concluded in his speech.<\/p>\n
YINENG Pharma’s participation in the J.P. Morgan Healthcare Conference represents more than a corporate milestone:<\/p>\n
- \n
- It marks the first systematic presentation of digitalized TCM innovation by a Chinese TCM CXO company at a top-tier global healthcare event<\/li>\n
- It signals the transition of TCM innovation from “Chinese characteristics” to “global consensus”<\/li>\n<\/ul>\n
With the continued expansion of the AI + CXO model, TCM is evolving from an emerging force into a key pillar of the global biopharmaceutical industry.<\/p>\n
![\"2026](\"https:\/\/www.medgencetec.com\/uploads\/2026-J.P.-Morgan-Healthcare-Conference-3.jpg\")
<\/p>\nYINENG Pharma, driven by professional R&D and digital empowerment, is positioning itself at the forefront of this transformation—charting a new future for TCM in the global healthcare landscape.<\/p>\n
Media Contact<\/span>
Company Name:<\/strong> Hunan Yineng Biopharmaceuticals Co., Ltd.<\/a>
Email:<\/strong> Send Email<\/a>
Country:<\/strong> China
Website:<\/strong> https:\/\/www.medgencetec.com\/<\/a><\/p>\n<\/p>\n","protected":false},"excerpt":{"rendered":"
In January, as the tides of the Pacific signal new directions for the global biopharmaceutical industry, the 44th J.P. Morgan Healthcare Conference successfully concluded on January 15, 2026, in San<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[],"tags":[],"_links":{"self":[{"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/posts\/548483"}],"collection":[{"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/comments?post=548483"}],"version-history":[{"count":0,"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/posts\/548483\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/media?parent=548483"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/categories?post=548483"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/tags?post=548483"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}